New York State Common Retirement Fund
OBIO icon

New York State Common Retirement Fund’s Orchestra BioMed OBIO Stock Holding History

New York State Common Retirement Fund’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,623
Closed -$15.5K – 3296
2025
Q1 		$15.5K Hold
3,623
– – ﹤0.01% 3017
2024
Q4 		$14.5K Hold
3,623
– – ﹤0.01% 3088
2024
Q3 		$18.6K Hold
3,623
– – ﹤0.01% 3049
2024
Q2 		$29.5K Sell
3,623
-579
-14% -$3.35K ﹤0.01% 3181
2024
Q1 		$22.1K Buy
4,202
+579
+16% +$3.92K ﹤0.01% 3130
2023
Q4 		$33.1K Sell
3,623
-7,931
-69% -$54.1K ﹤0.01% 3086
2023
Q3 		$101K Buy
11,554
+154
+1% +$1.03K ﹤0.01% 2721
2023
Q2 		$79.8K Buy
+11,400
New +$173K ﹤0.01% 3003

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund's OBIO Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Orchestra BioMed (OBIO) in Q2 2025, closing a stake of 3,623 shares — an estimated $15.5K sold.

New York State Common Retirement Fund first reported a position in OBIO in Q2 2023 and held it in 8 quarters. The position peaked at $101K in Q3 2023. 59 funds tracked by Wall St. Rank hold OBIO as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Orchestra BioMed position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 3,623 Orchestra BioMed shares in Q2 2025, an estimated $15.5K.
  • New York State Common Retirement Fund first reported a position in Orchestra BioMed in Q2 2023 and held it in 8 quarters.
  • New York State Common Retirement Fund's Orchestra BioMed position peaked at $101K in Q3 2023.
  • 59 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.